Aspect Biosystems

📍 Vancouver, Canada🗓 Founded 2013👥 107 employees💰 Last funded Jan 2020
Biotechnology Research🌐 aspectbiosystems.com
Website LinkedIn
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases.
6
Total investors
0
Early stage
4
Mid stage
2
Late stage
2013
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Canada
4
United States
2
Investor activity2016–2020 · investors recorded per year
20161201732019120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Aspect Biosystems?
Aspect Biosystems has 6 investors on record on gritt.io, 4 mid-stage and 2 late-stage investors.
When did Aspect Biosystems last raise funding?
The most recent investment in Aspect Biosystems recorded on gritt.io was in January 2020.
When was Aspect Biosystems founded?
Aspect Biosystems was founded in 2013.
What industry is Aspect Biosystems in?
Aspect Biosystems operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Aspect Biosystems based?
Aspect Biosystems is headquartered in Vancouver, Canada.